18 /100
LOW RISK
Score updated May 30, 2026

DNTH — Dianthus Therapeutics, Inc. Dilution Risk Tracker

Track DNTH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DNTH — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DNTH.
🔔 Track DNTH — Get forecast alerts →

💹 Market Data

Market Cap$5.08B
Shares Outstanding54.67M
Float54.60M
Cash$1.11B
Debt$1.36M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.1% shares (2025Q4 vs prior)
167 institutional holders · 49.42M shares
#1 FMR LLC 6.43M shares
#2 WELLINGTON MANAGEMENT GROUP LLP 2.50M shares
#3 Octagon Capital Advisors LP 2.42M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.43M
Days to Cover14.3
% of Float11.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Mar 13, 2026
4 INSIDER TRANSACTION Mar 13, 2026
4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track DNTH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DNTH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DNTH
📊 DNTH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DNTH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.